Document is current
Any future updates will be listed below
-
Authors
Gantier, Malika http://orcid.org/0009-0007-2384-0458
Rispal, Raphaël
Fourrier, Angélique
Ménoret, Séverine
Delbos, Frédéric
Anegon, Ignacio
Nguyen, Tuan Huy
- License Information
-
More Information
Article History
Received: 10 November 2023
Accepted: 20 February 2024
First Online: 12 March 2024
Declarations
:
: The research protocol on human embryonic stem cells is authorized by the French Biomedicine Agency (Agence de la Biomédecine) under approval number RE18-007. All animal care and procedures performed in this study (Modèles d'hépatite fulminante induite chez la souris et traitement par une approche de cellules souches pluripotentes) were approved by the Animal Experimentation Ethics Committee of Pays de la Loire region, France, in accordance with the guidelines from the French National Research Council for the Care and Use of Laboratory Animals (Authorization Numbers: Apafis 21417; 10/01/2019) and were performed in accordance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines.
: Not applicable.
: MG, AF, FD and THN are employees of Goliver Therapeutics. THN is a shareholder of Goliver Therapeutics. The remaining authors declare that the research was conducted in the absence of competing interests.
